Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
March 17, 2015 9:04 AM EDTEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced the pricing of an underwritten public offering of 1,320,276 shares of its common stock at a price to the public of $42.00 per share. 1,190,476 shares are being sold by Eagle and 129,800 shares are being sold by certain stockholders of the... More
Eagle Pharmaceuticals (EGRX) Commences $50M Stock Offering
March 16, 2015 4:36 PM EDTEagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $50,000,000 of shares of its common stock. In addition, certain stockholders of the Company (the Selling Stockholders) are offering... More
